|
Q3 2022
|
1 |
0 |
|
13F-HR
|
11/14/2022 |
000142050622002165 |
|
Q2 2022
|
1 |
1,117 |
SRRA
|
13F-HR
|
8/10/2022 |
000142050622001456 |
|
Q1 2022
|
2 |
1,988 |
SRRA, ALNA
|
13F-HR
|
5/13/2022 |
000142050622000919 |
|
Q4 2021
|
43 |
1,298,925 |
ARQT, PHAT, IMAGO BIOSCIENCES INC, SNDX
|
13F-HR
|
2/8/2022 |
000142050622000158 |
|
Q3 2021
|
41 |
1,249,807 |
ARQT, PHAT, MIRM, IOVA
|
13F-HR
|
11/12/2021 |
000142050621001482 |
|
Q2 2021
|
34 |
1,084,327 |
ARQT, PHAT, PASG, MIRM
|
13F-HR
|
8/11/2021 |
000142050621001031 |
|
Q1 2021
|
35 |
1,246,792 |
ARQT, PHAT, PASG, MIRM
|
13F-HR
|
5/12/2021 |
000142050621000553 |
|
Q4 2020
|
35 |
1,298,563 |
ARQT, PHAT, PASG, TARS
|
13F-HR
|
2/11/2021 |
000142050621000194 |
|
Q3 2020
|
31 |
1,113,891 |
ARQT, PHAT, PCVX, MIRM
|
13F-HR
|
11/12/2020 |
000142050620001216 |
|
Q2 2020
|
26 |
1,138,800 |
ARQT, PHAT, PASG, PCVX
|
13F-HR
|
8/4/2020 |
000142050620000790 |
|
Q1 2020
|
25 |
881,971 |
ARQT, PHAT, PASG, IOVA
|
13F-HR
|
5/13/2020 |
000142050620000541 |
|
Q4 2019
|
20 |
596,227 |
PHAT, MIRM, KRYS, IOVA
|
13F-HR
|
2/13/2020 |
000142050620000189 |
|
Q3 2019
|
19 |
319,851 |
ANAB, MIRM, IOVA, KRYS
|
13F-HR
|
11/12/2019 |
000142050619001048 |
|
Q2 2019
|
18 |
390,265 |
ANAB, IOVA, KRYS, COLL
|
13F-HR
|
8/14/2019 |
000142050619000868 |
|
Q1 2019
|
17 |
415,414 |
ANAB, KRYS, COLL, GRTS
|
13F-HR
|
5/15/2019 |
000142050619000502 |
|
Q4 2018
|
17 |
387,573 |
ANAB, APTX, COLL, GRTS
|
13F-HR
|
2/11/2019 |
000142050619000130 |
|
Q3 2018
|
16 |
546,149 |
ANAB, APTX, ALNA, GRTS
|
13F-HR
|
11/14/2018 |
000142050618000990 |
|
Q2 2018
|
13 |
482,752 |
ANAB, APTX, COLL, ALNA
|
13F-HR
|
8/15/2018 |
000142050618000781 |
|
Q1 2018
|
10 |
602,641 |
ANAB, COLL, FOLD, IOVA
|
13F-HR
|
5/14/2018 |
000142050618000446 |
|
Q4 2017
|
9 |
616,613 |
ANAB, IGNYTA INC, FOLD, COLL
|
13F-HR
|
2/13/2018 |
000142050618000196 |
|
Q3 2017
|
8 |
280,433 |
ANAB, FOLD, IGNYTA INC, ALPN
|
13F-HR
|
11/13/2017 |
000142050617000744 |
|
Q2 2017
|
7 |
195,097 |
ANAB, FOLD, COLL, IGNYTA INC
|
13F-HR
|
8/14/2017 |
000142050617000607 |
|
Q1 2017
|
7 |
187,204 |
ANAB, COLL, FOLD, LBIO
|
13F-HR
|
5/12/2017 |
000142050617000312 |
|
Q4 2016
|
6 |
79,458 |
COLL, LBIO, CDTX, FOLD
|
13F-HR
|
2/13/2017 |
000142050617000146 |
|
Q3 2016
|
7 |
203,799 |
TBRA, COLL, FOLD, LBIO
|
13F-HR
|
11/14/2016 |
000142050616001352 |
|
Q2 2016
|
8 |
125,375 |
TBRA, GKOS, COLL, FOLD
|
13F-HR
|
8/9/2016 |
000142050616001157 |
|
Q1 2016
|
7 |
162,472 |
GKOS, COLL, FOLD, TBRA
|
13F-HR
|
5/13/2016 |
000142050616000971 |
|
Q4 2015
|
7 |
239,163 |
GKOS, COLL, SRRA, FOLD
|
13F-HR
|
2/11/2016 |
000142050616000752 |